FDA — authorised 23 June 1965
- Marketing authorisation holder: HIKMA MAPLE
- Status: approved
🇺🇸 Dopram in United States
FDA authorised Dopram on 23 June 1965
Marketing authorisations
FDA — authorised 23 June 1965
- Application: NDA014879
- Marketing authorisation holder: HIKMA
- Local brand name: DOPRAM
- Indication: INJECTABLE — INJECTION
- Status: approved
Dopram in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Neuroscience approved in United States
Frequently asked questions
Is Dopram approved in United States?
Yes. FDA authorised it on 23 June 1965; FDA authorised it on 23 June 1965.
Who is the marketing authorisation holder for Dopram in United States?
HIKMA MAPLE holds the US marketing authorisation.